INS and polycystic ovary syndrome: Our group has previously demonstrated that the coupling between insulin action and release of DCI-IPG mediator is impaired in obese women with PCOS, as compared to nonobese normal women, suggesting that the insulin-stimulated release of bioactive DCI-IPG mediator is defective in PCOS women with obesity [12].